Name: Biden’s HHS Freezes Trump Insulin, Epinephrine Rule Until March
Brand: bloomberglaw.com
SKU: bloomberglaw-com-35
Availability: OnlineOnly

critic

Biden’s HHS Freezes Trump Insulin, Epinephrine Rule Until March

preview

Free Newsletter Sign Up Login Log in to access all of your BLAW products Single Sign-On Free Newsletter Sign Up Mylan Inc.'s EpiPen dispenses epinephrine through an injection mechanism for people with severe allergies. Photographer: Joe Raedle/Getty Images The HHS Thursday froze the former Trump administration’s December drug policy that requires community health centers to pass on all their insulin and epinephrine discount savings to patients. Centers that don’t pass on the savings wouldn’t qualify for federal grants. The rule, which was in late December, is delayed until March 22, the Department of Health and Human Services said in a . This freeze is part of the Biden administration’s announced this week that will scrutinize the Trump administration’s health policies. If the previous administration’s policies raise “fact, law, or policy” concerns, the Biden HHS will delay them and consult with the Office of Management and Budget about other actions. Former HHS leaders argued the drug rule would benefit patients who struggle to pay for expensive insulin and allergy medication. However, the health centers said they already pass on those savings and this rule is merely an administrative burden that paints them as entities that price-gouge patients. It’s not clear how many facilities would have to follow the rule or face funding restrictions. To contact the reporter on this story: Jacquie Lee in Washington at To contact the editors responsible for this story: Fawn Johnson at ; Brent Bierman at To read more articles . Learn more about a . Jacquie Lee Reporter Document Final Rule © 2022 The Bureau of National Affairs, Inc. All Rights Reserved

Free Newsletter Sign Up Login Log in to access all of your BLAW products Single Sign-On Free Newsletter Sign Up Mylan Inc.'s EpiPen dispenses epinephrine through an injection mechanism for people with severe allergies. Photographer: Joe Raedle/Getty Images The HHS Thursday froze the former Trump administration’s December drug policy that requires community health centers to pass on all their insulin and epinephrine discount savings to patients. Centers that don’t pass on the savings wouldn’t qualify for federal grants. The rule, which was in late December, is delayed until March 22, the...

public

Jacquie Lee

bloomberglaw.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Biden’s HHS Freezes Trump Insulin, Epinephrine Rule Until March

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS